Bigfoot and Abbott Join Forces to Develop and Commercialize Diabetes Management Systems

Bigfoot Biomedical Inc. and Abbott Laboratories Inc. today signed a partnership agreement that calls for the integration of Abbott's FreeStyle Libre CGM into the artificial pancreas system Bigfoot is developing. The move is an endorsement for Abbott's no-calibration, easy-to-use CGM system over other major players in the CGM field, including Dexcom.

California-based startup Bigfoot Biomedical Inc. and diabetes giant Abbott Laboratories Inc. announced today they have inked a partnership to integrate Abbott's FreeStyleLibre continuous glucose monitoring (CGM) system into the smartloop automated insulin delivery system Bigfoot is developing

Jefferies analyst Raj Denhoy believes Bigfoot's decision to pick Abbott's FreeStyle Libre as the CGM for its diabetes management system...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Deals

More from Business